News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • Palantir shares jumped after reporting a quarter driven by 66% U.S. government revenue growth and above-consensus guidance.
  • Western Digital rose about 8% after unveiling targets for over 20% revenue CAGR and gross margins above 50%.
  • BlackSky shares rallied after securing multiple seven-figure contracts from an international defense customer for Gen-3 services.
  • Veradermics' IPO is set to price at the top of its $14–$16 range after heavy oversubscriptions and limited allocations.
  • Copenhagen's OMX C20 closed down 0.7% as several large caps slid, dragging national equity performance lower.
  • Blackstone says AI-driven disruption is a top strategic concern and is focusing investments on AI infrastructure and 'picks and shovels'.

Latest Articles

Leerink Cuts Moderna Price Target to $17 After Recordati Collaboration

Leerink Cuts Moderna Price Target to $17 After Recordati Collaboration

Leerink Partners lowered its price target for Moderna to $17 from $18 and retained an Underperform rating after the company disclosed a commercialization collaboration with Italian drugmaker Recordati for mRNA-3927, an investigational therapy for propionic acidemia. The new target sits well below Moderna's prevailing market price and reflects Leeri…

Jefferies Moves Fugro to Hold as Offshore Wind Sentiment Brightens

Jefferies Moves Fugro to Hold as Offshore Wind Sentiment Brightens

Jefferies upgraded Fugro NV to a "hold" rating from "underperform" after noting signs of a recovery in offshore wind sentiment. The Dutch geodata firm's shares climbed over 6% on the upgrade, even as Jefferies projects a sharp decline in fiscal 2025 earnings driven by weakness in offshore wind and oil and gas project delays. The broker highlighted …

BofA Lifts MongoDB Target to $500, Cites Faster Atlas Growth and AI Push

BofA Lifts MongoDB Target to $500, Cites Faster Atlas Growth and AI Push

BofA Securities raised its price target on MongoDB to $500 from $480 while retaining a Buy rating, citing accelerating Atlas revenue growth and an expanding AI and modernization product set. The new target implies roughly 34% upside from MongoDB's current share price of $374.02, well above the consensus upside of 11%. Analysts and peers have reacte…

Jefferies Lifts Dow Price Target to $28, Cites Margin Recovery Path

Jefferies Lifts Dow Price Target to $28, Cites Margin Recovery Path

Jefferies raised its 12-month price target on Dow Inc. to $28 from $23 while retaining a Hold rating, a level that sits close to the company's recent trading price and a third-party fair-value metric. The firm pointed to stronger-than-expected fourth-quarter EBITDA and expects margin improvement across 2026, although near-term demand is muted and c…

Patagonian blazes overwhelm protected forests as austerity cuts draw fire

Patagonian blazes overwhelm protected forests as austerity cuts draw fire

Widespread wildfires in Patagonia have scorched an area more than twice the size of Buenos Aires, breached the Los Alerces National Park and prompted a government emergency declaration in four southern provinces. Critics say steep budget cuts to wildfire prevention and response under President Javier Milei have weakened preparedness, while authorit…

Novo Nordisk's China Chief to Exit as Local Competition Intensifies

Novo Nordisk's China Chief to Exit as Local Competition Intensifies

Novo Nordisk said Christine Zhou, the executive overseeing its China business, will leave the company at the end of March. Zhou led the launches of Ozempic, approved in China in 2021, and the obesity medicine Wegovy. Her exit occurs amid rising competition from Eli Lilly and an expanding cohort of domestic drugmakers, with Sciwind Biosciences winni…

BTIG nudges Stryker price target to $412 after Q4 beat; keeps Buy rating

BTIG nudges Stryker price target to $412 after Q4 beat; keeps Buy rating

BTIG raised its 12-month price target on Stryker to $412 from $410 while retaining a Buy rating following the medical-device maker's fourth-quarter 2025 results. Stryker posted quarterly revenue of $7.2 billion and adjusted EPS of $4.47, both modestly ahead of expectations. Management issued fiscal 2026 guidance for high-single-digit organic growth…

Trump Orders and Actions Reshape U.S. Museums, Parks and Cultural Bodies

Trump Orders and Actions Reshape U.S. Museums, Parks and Cultural Bodies

Since returning to the White House, President Donald Trump has issued directives and moved to alter how federal cultural and historical institutions present U.S. history. Actions include a 2025 executive order targeting so-called 'anti-American ideology' at the Smithsonian, a review of national park signage, removal of slavery exhibits, restoration…

U.S. Energy Aid for Ukraine Caught in Bureaucratic Gridlock as Winter Deepens

U.S. Energy Aid for Ukraine Caught in Bureaucratic Gridlock as Winter Deepens

Hundreds of millions of dollars in U.S. energy assistance earmarked to help Ukraine import liquefied natural gas and repair power infrastructure have not been disbursed, according to multiple officials. Sources say the funds were notified to Congress under the previous administration but stalled after the U.S. Agency for International Development (…